Register | Login
Login
Sign in with:
---------- OR ----------
Create Account | Login
Create account
As a Member You Can:
  • Join clubs to discuss your interests
  • Connect with people like you
  • Share information, seek advice, get support

   
India Parenting
You are here: Home > Message Boards > Expecting Parents >  Medication Effect on Foetus >Systemic Antacid
Start a new Topic
 
Search a question
 
Medication Effect on Foetus:Systemic Antacid
2007-04-13
Name: Anandarup Datta
What is the effect of Pantoprazole sod. (40 mg daily) on embryo, can any body ans pl?
 
2007-10-17
#1
Name: Anurag
Subject:  your que
The recent multicentre, prospective controlled cohort study mentioned above followed 295 pregnancies exposed to PPIs, including 53 exposed to pantoprazole, and compared pregnancy outcomes with those of 868 control subjects.6 Rate of major congenital malformations in the pantoprazole group was 2.1% (1/48) compared with 3.8% in the control group (30/792). There was no pattern of anomalies.

A 42-year-old woman was studied over a 24-hour period after oral administration of 40 mg of pantoprazole.8 A milk-to-plasma ratio of 0.022 was observed 2 hours after drug administration. The relative dose to the infant was estimated to be 7.3 μg of pantoprazole, which is equivalent to 0.14% of the weight-normalized dose received by the mother. The mother reported no adverse events in the infant. Because pantoprazole is unstable in acidic pH, the systemic dose received by the infant could have been lower.

Use Omeprazole instead

A multicentre prospective cohort study conducted by Motherisk looked at the outcomes among 113 mothers exposed to omeprazole during pregnancy, including 101 mothers exposed during organogenesis.3 Two control groups were used: a disease-paired control group using histamine H2-blockers and a control group of healthy women exposed to nonteratogenic medications. The rate of major malformations in the omeprazole group (5%) did not differ significantly from rates in the nonteratogenic drug control group (3%) and in the disease-paired control group (3%). Rates of spontaneous abortions, preterm deliveries, cesarean sections, and neonatal health problems birth weight and gestational age at delivery were also comparable in the 3 groups.

The Motherisk Program also conducted a meta-analysis on use of PPIs during pregnancy.4 All exposures to PPIs (593 cases) had a relative risk of 1.18 (95% confidence interval [CI] 0.72 to 1.94) and exposures to omeprazole only (534 cases) had a relative risk of 1.05 (95% CI 0.59 to 1.85), indicating no increase in risk of malformations.

A large cohort study from the Swedish Medical Birth Registry reported on 955 infants whose mothers used omeprazole during pregnancy.5 In this report, 863 of the infants were exposed at least during the first trimester, and 92 were exposed only after the first trimester. Birth weights, rates of congenital malformations and perinatal death, and low Apgar scores in the exposed group were comparable to rates observed in the general Swedish population.

A recent multicentre, prospective controlled cohort study followed 295 pregnancies where mothers were exposed to omeprazole (233 exposed during the first trimester), 62 pregnancies where mothers were exposed to lansoprazole, and 53 pregnancies where mothers were exposed to pantoprazole. The pregnancy outcomes of these mothers were compared with those of 868 control subjects.6 In the omeprazole group, 3.6% (9/249) of babies were born with malformations, a rate similar to the 3.8% (30/792) observed in the control group. There was no pattern of anomalies among the babies born with birth defects.

Administration of oral omeprazole to a 41-year-old woman during the third trimester of pregnancy, after ranitidine and cisapride failed to control her refractory gastroesophageal reflux disorder, was reported.7 No adverse fetal effects were apparent, and the patient elected to continue omeprazole therapy (20 mg/d) while breastfeeding. Peak omeprazole concentrations in breast milk of 58 nM at 3 hours after ingestion of the drug were lower than 7% of the peak maternal serum concentration (950 nM at 4 h), indicating limited excretion into milk.

The conclusion is:-

Overall, a rule of thumb during pregnancy is to choose an older agent in a pharmacologic class for which there are more fetal safety data that indicate the medication is effective. Applying this rule to PPIs makes omeprazole the drug of choice for now.

A cohort study of 113 women found no associated anomalies (relative risk=1.94 95% confidence interval, 0.36-10.36).[11] Pantoprazole, lansoprazole and rabeprazole are category B medications.

Medications in category A are not contraindicated for pregnancy, and are considered to be of a high safety level. Medications in category B have never been shown to have a risk for the baby, but there are not adequate studies to rule out risk. Category C medications are not recommended for pregnant women unless the potential benefit outweighs the potential risk. Category D have proven risks that may still be outweighed by benefits. For Category X medications, there is definitely risk to the baby and the risk outweighs the benefits.
In a study published this year,[40] 295 pregnancies exposed to omeprazole, 62 to lansoprazole and 53 to pantoprazole were compared with 868 pregnant controls for the development of congenital abnormalities. As with other studies, the rate of congenital abnormalities did not differ between the exposed and control groups: omeprazole nine of 249 (3.6%), lansoprazole two of 51 (3.9%) and pantoprazole one of 48 (2.1%) vs. controls 30 of 792 (3.8%). No differences were found when exposure was limited to the first trimester.


i thin this will help you
Reply to Original MessageReply to Original Message   Reply to Original Message Reply to This Message   Msg Objection   Go to Top

All tips on Expecting Parents
You ever wanted in one place.
No need to go anywhere else.
& Answers to Topic :
Systemic Antacid

Thanks for subscribing
You are already a member, please login to subscribe

------ OR ------

Last 7 Posts of this Board
RE:Used candiderma cream
Hi Mother,
It might due to any sensation problem so it would be better you go for doctor to have treatment and then be safe while using it because you had kid know.... - Basu [View Message]
RE:progestrone-susten 200
Hi Kr,
Progesterone is not so good for health and even it would not cause any harm to baby also.But it would be avoid using pills regarding that.... - Gita [View Message]
RE:Eno intake during pregnancy
Hi Dora,
If you had acidity problem then you can prepare anti medicine for it at home only which would be safe to you and your baby.... - Hayaathi [View Message]
RE:Is it safe to have Pudin HaraNULL
Hi Rita,
During pregnancy how many complications it would include by reading all the messages am able to know all of them.So it can be suggested to other.

... - Siri [View Message]
RE:Is Naturogest safe during pregnancy?
Hi Deepa,
During pregnancy you have to look after your health.But you should go for regular check up and doctor would be good and must give response to you only.... - Naina [View Message]
RE:Used candiderma cream
Hi Mother,
When you have given birth why does the cream which you are using would effect the baby.It would effect when you use at your breast part know.Your message was not so clear.... - Shiny [View Message]
RE:progestrone-susten 200
Hi Kr,
Progesterone does not cause any harm but you should not prefer that because some medicines would not work properly for us in time.But do take some other tablets which are not heavy dosaged.... - Kaira [View Message]

Make a Notebook Computer Video..